Federation des caisses Desjardins du Quebec’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91M Buy
123,272
+2,801
+2% +$120K 0.02% 487
2026
Q1
$4.43M Sell
120,471
-60,079
-33% -$2.85M 0.02% 487
2025
Q4
$9.19M Sell
180,550
-362,901
-67% -$18.6M 0.04% 299
2025
Q3
$30.2M Buy
543,451
+192,476
+55% +$11.3M 0.12% 139
2025
Q2
$24.2M Buy
350,975
+242,128
+222% +$16.5M 0.11% 150
2025
Q1
$7.56M Buy
108,847
+31,293
+40% +$2.58M 0.04% 275
2024
Q4
$6.67M Buy
77,554
+34,294
+79% +$3.71M 0.03% 283
2024
Q3
$5.15M Buy
43,260
+3,259
+8% +$435K 0.03% 333
2024
Q2
$5.71M Sell
40,001
-10,868
-21% -$1.44M 0.03% 302
2024
Q1
$6.53M Buy
50,869
+16,880
+50% +$2.01M 0.05% 262
2023
Q4
$3.52M Buy
33,989
+4,556
+15% +$451K 0.03% 322
2023
Q3
$2.68M Sell
29,433
-97,897
-77% -$8.62M 0.03% 362
2023
Q2
$10.3M Buy
127,330
+6,194
+5% +$506K 0.1% 177
2023
Q1
$9.64M Buy
121,136
+2,802
+2% +$199K 0.11% 164
2022
Q4
$8.01M Buy
118,334
+10,594
+10% +$621K 0.09% 175
2022
Q3
$5.37M Buy
107,740
+86,456
+406% +$4.63M 0.06% 226
2022
Q2
$1.19M Sell
21,284
-3,730
-15% -$207K 0.01% 530
2022
Q1
$1.39M Sell
25,014
-670
-3% -$34.4K 0.01% 545
2021
Q4
$1.44M Sell
25,684
-3,804
-13% -$206K 0.01% 542
2021
Q3
$1.42M Sell
29,488
-9,306
-24% -$450K 0.01% 596
2021
Q2
$1.62M Sell
38,794
-14,942
-28% -$579K 0.02% 563
2021
Q1
$1.81M Sell
53,736
-3,724
-6% -$133K 0.02% 510
2020
Q4
$2.01M Sell
57,460
-2,870
-5% -$99.2K 0.02% 462
2020
Q3
$2.09M Sell
60,330
-13,470
-18% -$449K 0.03% 375
2020
Q2
$2.42M Sell
73,800
-74,060
-50% -$2.36M 0.04% 339
2020
Q1
$4.45M Sell
147,860
-164,968
-53% -$4.91M 0.08% 192
2019
Q4
$9.05M Sell
312,828
-17,434
-5% -$483K 0.13% 132
2019
Q3
$8.54M Buy
330,262
+5,588
+2% +$141K 0.12% 142
2019
Q2
$8.29M Buy
324,674
+11,684
+4% +$289K 0.12% 148
2019
Q1
$8.19M Sell
312,990
-1,170
-0.4% -$28.8K 0.13% 150
2018
Q4
$7.24M Buy
314,160
+21,272
+7% +$473K 0.12% 152
2018
Q3
$6.9M Buy
292,888
+3,466
+1% +$84.6K 0.1% 177
2018
Q2
$6.67M Sell
289,422
-1,004
-0.3% -$23.9K 0.1% 185
2018
Q1
$7.15M Buy
290,426
+11,560
+4% +$304K 0.11% 176
2017
Q4
$7.48M Sell
278,866
-5,380
-2% -$137K 0.11% 174
2017
Q3
$6.84M Sell
284,246
-12,512
-4% -$283K 0.11% 178
2017
Q2
$6.36M Buy
+296,758
New +$5.99M 0.1% 181

Other funds holding NVO

Federation des caisses Desjardins du Quebec's NVO Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Novo Nordisk (NVO) stake by 2.3% in Q2 2026, buying an estimated $120K and bringing the position to 123,272 shares worth $5.91M. The position accounts for 0.02% of the portfolio, ranked #487.

Federation des caisses Desjardins du Quebec first reported a position in NVO in Q2 2017 and has held it in 37 quarters since. The position peaked at $30.2M in Q3 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 123,272 shares of Novo Nordisk worth $5.91M as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 2,801 Novo Nordisk shares in Q2 2026, an estimated $120K.
  • Novo Nordisk made up 0.02% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #487 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Novo Nordisk in Q2 2017 and has held it in 37 quarters since.
  • Federation des caisses Desjardins du Quebec's Novo Nordisk position peaked at $30.2M in Q3 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.